COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03585855
Recruitment Status : Terminated (Safety reasons)
First Posted : July 13, 2018
Last Update Posted : July 25, 2019
Slovenian Research Agency
Information provided by (Responsible Party):
Veceric-Haler Zeljka, University Medical Centre Ljubljana

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 23, 2019
Actual Study Completion Date : July 23, 2019